Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 22, 2022 - Issue 2
Submit an article Journal homepage
3,003
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Cost-utility analysis of ceftazidime-avibactam versus colistin-meropenem in the treatment of infections due to Carbapenem-resistant Klebsiella pneumoniae in Colombia

FA Varón-Vegaa Universidad de Navarra, Research Deparment, Pamplona, España;b Fundación Neumológica Colombiana, Research Deparment, Bogotá, ColombiaView further author information
,
E Lemosc Pfizer SAS, Hospitals Medical, Bogotá, ColombiaView further author information
,
Gamboa N Castañod Pfizer SAS, Health Outcomes, Bogotá, ColombiaORCID Iconhttps://orcid.org/0000-0001-7383-6800View further author information
ORCID Icon &
JM Reyesd Pfizer SAS, Health Outcomes, Bogotá, ColombiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0806-7173View further author information
ORCID Icon
Pages 235-240 | Received 21 Apr 2021, Accepted 03 Aug 2021, Published online: 18 Aug 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.